Laekna (2105.HK) announced that the U.S. Food and Drug Administration (FDA) has approved the IND for LAE120, an internally discovered USP1 inhibitor, for the treatment of advanced solid tumors. LAE120 ...
TCL, a pioneer in display across feature-rich smartphones, tablets, and connected devices, has showcased its commitment to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback